Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 2
1949 2
1950 8
1951 5
1952 9
1953 3
1954 2
1955 3
1956 4
1957 5
1958 4
1959 8
1960 3
1961 4
1962 1
1963 4
1964 4
1965 3
1966 5
1967 8
1968 3
1969 7
1970 6
1971 6
1972 7
1973 1
1974 3
1975 6
1976 2
1977 4
1978 2
1979 6
1981 10
1982 10
1983 6
1984 4
1985 2
1986 1
1987 2
1988 1
1989 1
1990 2
1992 1
1994 1
1995 1
1996 1
1997 1
2000 1
2001 1
2002 1
2003 1
2004 1
2008 2
2013 3
2014 2
2015 5
2016 1
2017 8
2018 4
2019 5
2020 9
2021 15
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Results by year
Filters applied: . Clear all
Page 1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Gautret P, et al. Among authors: courjon j. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. PMID: 32205204 Free PMC article. Clinical Trial.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy study group. Ader F, et al. Among authors: courjon j. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26. Clin Microbiol Infect. 2021. PMID: 34048876 Free PMC article. Clinical Trial.
Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.
Matt M, Duran C, Courjon J, Lotte R, Moing VL, Monnin B, Pavese P, Chavanet P, Khatchatourian L, Tattevin P, Cattoir V, Lechiche C, Illes G, Lacassin-Beller F, Senneville E, Dinh A; Dalbavancin French Study Group. Matt M, et al. Among authors: courjon j. J Glob Antimicrob Resist. 2021 Jun;25:341-345. doi: 10.1016/j.jgar.2021.03.026. Epub 2021 May 4. J Glob Antimicrob Resist. 2021. PMID: 33962065 Free article. Review.
Proteinuria as a Biomarker for COVID-19 Severity.
Ouahmi H, Courjon J, Morand L, François J, Bruckert V, Lombardi R, Esnault V, Seitz-Polski B, Demonchy E, Dellamonica J, Boyer-Suavet S. Ouahmi H, et al. Among authors: courjon j. Front Physiol. 2021 Mar 9;12:611772. doi: 10.3389/fphys.2021.611772. eCollection 2021. Front Physiol. 2021. PMID: 33767630 Free PMC article.
Medical table: A major tool for antimicrobial stewardship policy.
Roger PM, Demonchy E, Risso K, Courjon J, Leroux S, Leroux E, Cua É. Roger PM, et al. Among authors: courjon j. Med Mal Infect. 2017 Sep;47(5):311-318. doi: 10.1016/j.medmal.2017.03.005. Epub 2017 Apr 28. Med Mal Infect. 2017. PMID: 28457702 Review.
Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice.
Dufies O, Doye A, Courjon J, Torre C, Michel G, Loubatier C, Jacquel A, Chaintreuil P, Majoor A, Guinamard RR, Gallerand A, Saavedra PHV, Verhoeyen E, Rey A, Marchetti S, Ruimy R, Czerucka D, Lamkanfi M, Py BF, Munro P, Visvikis O, Boyer L. Dufies O, et al. Among authors: courjon j. Nat Microbiol. 2021 Mar;6(3):401-412. doi: 10.1038/s41564-020-00832-5. Epub 2021 Jan 11. Nat Microbiol. 2021. PMID: 33432150 Free PMC article.
Antimicrobial stewardship policy: time to revisit the strategy?
Roger PM, Courjon J, Léotard S, Déchamp C, Négrin N, Vassallo M; Network for Infectious Diseases Paca-Est. Roger PM, et al. Among authors: courjon j. Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2167-70. doi: 10.1007/s10096-015-2483-x. Epub 2015 Sep 19. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26387088 Review.
Epidemiology of human common coronavirus acquisition in pilgrims.
Dao TL, Hoang VT, Ly TDA, Goumballa N, Courjon J, Memish Z, Sokhna C, Raoult D, Parola P, Gautret P. Dao TL, et al. Among authors: courjon j. Travel Med Infect Dis. 2020 Sep-Oct;37:101845. doi: 10.1016/j.tmaid.2020.101845. Epub 2020 Aug 14. Travel Med Infect Dis. 2020. PMID: 32805418 Free PMC article. No abstract available.
Erythematous skin nodules during treatment of Whipple's disease.
Sanchez A, Del Giudice P, Mantion C, Mazellier S, Boukari F, Roger PM, Courjon J. Sanchez A, et al. Among authors: courjon j. Infect Dis Now. 2021 Jun;51(4):397-399. doi: 10.1016/j.medmal.2020.10.006. Epub 2020 Oct 16. Infect Dis Now. 2021. PMID: 33075401 No abstract available.
239 results